Aptamers Market Expected to Reach USD 4.33 Billion Globally in 2019


Posted March 27, 2015 by Alinajohn

Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

 
According to a new market report published by Transparency Market Research Aptamers Market (By Types - Nucleic Acid Aptamers and Peptide Aptamers; By Applications - Therapeutics Development, Diagnostics, Research and Development Applications and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019, the global aptamers market was valued at USD 93.0 million in 2012 and is estimated to reach USD 4,333.0 million in 2019, growing at a CAGR of 73.1% from 2013 to 2019.

Browse the full Aptamers Market report at http://www.transparencymarketresearch.com/aptamers-market.html

Aptamers are single-stranded nucleic acid oligonucleotide or peptide molecules. Aptamers can bind with a range of target molecules such as proteins, carbohydrates, ions and viruses. Aptamer technology is widely used in laboratory diagnosis, molecular recognition, pharmaceutical studies, drug discovery and disease treatment. Moreover, these play an important role in the production of improved and cost-effective medicines. Increasing scientific research activities in aptamer technology and rising participation of private organizations for the development of aptamers would boost the growth of the aptamers market globally. Furthermore, collaboration of key players to develop innovative aptamer technologies would drive market growth. For example, Aptamer Group focuses on collaborating with government agencies and academic partners for the development of effective and innovative aptamer technologies. These collaborations would establish a healthy platform for the development of aptamers, which in turn would accelerate market growth. However, strict regulations and ethical issues related to aptamers would restrain the growth of the market.

The aptamers market is segmented by types and by applications. The aptamers market by types is segmented into nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers segment accounted for the largest share of the aptamers market in 2012. It is expected to dominate the market during the forecast period. Growth in this segment is attributed to increasing use of nucleic acid aptamers in research and development. Additionally, nucleic acid aptamers is projected to be the fastest growing segment during the forecast period. The aptamers market, by application is segmented into therapeutics development, diagnostics, research and development applications and others. The diagnostics application segment is likely to grow consistently due to increasing use of aptamers in biomedical diagnostics, molecular imaging and development of disease related biomarkers. However, the therapeutics development application segment is estimated to grow at the highest CAGR due to increasing research and development activities in aptamer technology to develop novel therapeutic agents.

Browse the full Press Release Report : http://www.transparencymarketresearch.com/pressrelease/aptamers-market.htm


North America accounted for the largest share of the global aptamers market in 2012. Presence of a large number of key players and increasing research and development activities in aptamer technology in North America are the major factors contributing to the growth of aptamers market. Europe accounted for the second largest share i.e., over 35% of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019 due to increasing initiatives undertaken by governments for the development of aptamers. There is intense competition in the global aptamers market. Manufacturers are increasing their investment in aptamer technology. The global aptamers market includes major companies such as Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc. and Aptagen, Inc.

The global aptamers market is segmented into the following categories:
Aptamers Market, by Types
Nucleic Acid Aptamers
Peptide Aptamers
Aptamers Market, by Applications
Therapeutics Development
Diagnostics
Research and Development Application
Others
Aptamers Market, by Geography
North America
Europe
Asia-Pacific
Rest of World (RoW)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1335

Key Questions This Study Will Answer

What is the market size and potential for Aptamers Market products?
Which segment of Aptamers Market is growing the fastest? How long will it continue to grow, and at what rate?
What is the greatest challenge faced by the Aptamers Market and how can it be overcome?
Are the products and services offered currently meeting customer needs, or are there additional developments needed?

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Alina
Website http://www.transparencymarketresearch.com/aptamers-market.html
Phone 866-552-3453
Business Address State Tower, 90 State Street, Suite 700,
Albany NY - 12207 United States
Country India
Categories Advertising , Business
Tags aptamers market
Last Updated March 27, 2015